New study personalizes hodgkin lymphoma treatment for kids

NCT ID NCT03755804

First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 24 times

Summary

This study tests whether giving different chemotherapy combinations based on a patient's risk level can improve outcomes for children and young adults with Hodgkin lymphoma. About 232 participants will receive one of three treatment plans, with radiation only if needed. The goal is to boost response rates and reduce long-term side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Dana Farber Cancer Institute

    Boston, Massachusetts, 02215, United States

  • Lucile Packard Children's Hospital Stanford University

    Palo Alto, California, 94304, United States

  • Maine Children's Cancer Program

    Scarborough, Maine, 04074, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • St. Jude Affiliate Baton Rouge Clinic (Our Lady of the Lakes Regional Medical Center)

    Baton Rouge, Louisiana, 70809, United States

  • St. Jude Affiliate Clinic at Novant Health Hemby Children's Hospital

    Charlotte, North Carolina, 28204, United States

  • St. Jude Children's Research Hospital

    Memphis, Tennessee, 38105, United States

  • St. Jude Midwest Affiliate - Peoria

    Peoria, Illinois, 61637, United States

Conditions

Explore the condition pages connected to this study.